🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
With the development of KIT mutation and KIT tyrosine kinase inhibitor imat...
Status
Completed
Location
Asan Medical Center
Start Date
2019-05-27
Trial ID
NCT03944304
Treatments Being Tested
This is aPhase II Study of Leronlimab (PRO 140) in combination with Regoraf...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-09-20
Trial ID
NCT05730673
The purpose of this study is to evaluate the efficacy and safety of rivocer...
Status
Recruiting
Location
Asan Medical Center, University of Ulsan College of Medicine
Start Date
2023-09-06
Trial ID
NCT05905887
Treatments Being Tested
Combination of anti-angiogenic molecular targeted therapy and anti- program...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2020-12-16
Trial ID
NCT04183088
New drug efficacy in ES has been disappointing in the last decades and no n...
Status
Active Not Recruiting
Location
Queensland Children's Hospital
Start Date
2023-06-16
Trial ID
NCT05830084
Treatments Being Tested
Phase I: Determine the maximum tolerated dose of combination of Regorafenib...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06-23
Trial ID
NCT02168777
Treatments Being Tested
The present protocol (STRAT-aHCC trial) aims to prospectively evaluate the ...
Status
Active Not Recruiting
Location
ICESP - Instituto do Câncer do Estado de São Paulo
Start Date
2023-09-10
Trial ID
NCT05622136
Treatments Being Tested